Prothena | PRTA - EPS Earnings Per Share


Prothena reported $-0.36 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.10 -0.68 Nov/05
-0.36 0.32 -2.34 Aug/06
FY2027Q1 Mar/2026 0.60 -0.35 -1.12 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0.09 0.09 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Exelixis USD 0.94 0.03 Sep/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
MacroGenics USD 0.31 0.89 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Prothena USD -0.36 0.96 Jun/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026